Recombinant Human TNFRSF12A protein
Cat.No. : | TNFRSF12A-582H |
Product Overview : | Recombinant Human TNFRSF12A protein was expressed in Escherichia coli. |
- Specification
- Gene Information
- Related Products
Description : | Human TNF-related weak inducer of apoptosis receptor (TWEAKR) also known as Tumor necrosis factor receptor superfamily member 12A precursor (gene name TNFRSF12A) or fibroblast growth factor-inducable 14 kD protein, is distantly related to the TNFR family, containing one cysteine-rich domain in the extracellular region and a TNFR-associated factor binding domain but does not contain a death domain (DD) cytoplasmic region. It is expressed in the spleen, thymus, peripheral blood lymphocytes, colon, and small intestine. Signal transduction by TWEAK receptor can be activated by either the membrane anchored or the soluble TWEAK. In addition, It plays a role in TWEAK-induced endothelial cell migration, proliferation, and angiogenesis. Human and mouse TWEAK R share 82 % a.a. sequence identity. |
Source : | E.coli |
Species : | Human |
Form : | Lyophilized from a 0.2μm filtered concentrated solution in PBS, pH 7.4. |
Bio-activity : | Fully biologically active when compared to standard. The ED50 as determined by inhibiting TWEAK-dependent proliferation of human umbilical vein endothelial cells (HUVEC) is less than 30 ng/ml, corresponding to a specific activity of > 3.3 × 10⁴ IU/mg, in the presence of 15 ng/ml of rHuTWEAK. |
Molecular Mass : | Approximately 5.6 kDa, a single non-glycosylated polypeptide chain containing 53 amino acids. |
Protein length : | 53 |
AA Sequence : | EQAPGTAPCSRGSSWSADLDKCMDC ASCRARPHSDFCLGCAAAPPAPFRL LWP |
Endotoxin : | Less than 1 EU/μg of rHuTWEAK Receptor as determined by LAL method. |
Purity : | >95% by SDS-PAGE and HPLC analysis. |
Storage : | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 centigrade as supplied. 1 month, 2 to 8 centigrade under sterile conditions after reconstitution. 3 months, -20 to -70 centigrade under sterile conditions after reconstitution. |
Reconstitution : | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤-20 centigrade. Further dilutions should be made in appropriate buffered solutions. |
Gene Name : | TNFRSF12A |
Official Symbol : | TNFRSF12A |
Synonyms : | TNFRSF12A; tumor necrosis factor receptor superfamily, member 12A; tumor necrosis factor receptor superfamily member 12A; CD266; FN14; TweakR; tweak-receptor; FGF-inducible 14; type I transmembrane protein Fn14; fibroblast growth factor-inducible immediate-early response protein 14; TWEAKR; |
Gene ID : | 51330 |
mRNA Refseq : | NM_016639 |
Protein Refseq : | NP_057723 |
MIM : | 605914 |
UniProt ID : | Q9NP84 |
Products Types
◆ Recombinant Protein | ||
TNFRSF12A-1646R | Recombinant Rhesus Monkey TNFRSF12A Protein, hIgG1 tagged | +Inquiry |
TNFRSF12A-471H | Recombinant Human TNFRSF12A Protein, Fc-tagged | +Inquiry |
TNFRSF12A-312H | Recombinant Active Human TNFRSF12A Protein (ECD), Fc-His-tagged(C-ter) | +Inquiry |
TNFRSF12A-441H | Recombinant Human TNFRSF12A Protein, His&GST-tagged | +Inquiry |
Tnfrsf12a-2085M | Recombinant Mouse Tnfrsf12a, Fc Chimera | +Inquiry |
◆ Lysates | ||
TNFRSF12A-1560HCL | Recombinant Human TNFRSF12A cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionSome studies suggest that TNFRSF12A may play a role in cardiovascular diseases, and targeting it could be a potential therapeutic strategy, but more research is needed.
Research indicates that elevated levels of TNFRSF12A may serve as a diagnostic marker for certain cancers, providing valuable information for disease detection.
As of now, there are no FDA-approved drugs specifically targeting TNFRSF12A. However, research is ongoing to develop targeted therapies.
TNFRSF12A is known to modulate inflammatory responses, and dysregulation of its signaling pathways may contribute to chronic inflammatory conditions.
TNFRSF12A is being explored as a potential target for immunotherapy in cancer, with studies investigating its role in modulating the immune response.
Customer Reviews (3)
Write a reviewThe manufacturer's commitment to delivering excellent technical support further enhances the experience, offering timely resolutions to any challenges I may encounter.
the TNFRSF12A protein surpasses expectations in terms of quality, meeting the rigorous demands of my experiments.
With the TNFRSF12A protein and the manufacturer's support, I can confidently pursue my research goals and achieve meaningful outcomes.
Ask a Question for All TNFRSF12A Products
Required fields are marked with *
My Review for All TNFRSF12A Products
Required fields are marked with *
Inquiry Basket